Galaxy DA2PPv (Canada)

Canine Distemper-adenovirus Type 2-parainfluenza-parvovirus Vaccine

MODIFIED LIVE VIRUS

For veterinary use in dogs only

Product Description

Galaxy™ DA2PPv vaccine is a modified live virus vaccine for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis) and adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus. Data indicate the development of corneal opacity is not associated with the use of this product.

Galaxy DA2PPv Dosage And Administration

Transfer contents of the sterile diluent vial to the Galaxy DA2PPv vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.

Inject one dose (1 mL) subcutaneously or intramuscularly. The initial dose may be given at 6 weeks of age or older. Repeat at 2 to 4 week intervals until the dog is 12 weeks of age. A minimum of two doses is required for primary immunization. Annual revaccination with one dose is recommended.

Precautions

- Store at 2°- 7°C.

- Do not freeze.

- Do not mix with other vaccines.

- Use new, non-chemically sterilized needles and syringes.

- Burn vaccine container and all unused contents.

Warnings

- Contains gentamicin as a preservative.

- Vaccinate only healthy, non-parasitized dogs.

- Do not vaccinate pregnant bitches.

- The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions.

Antidote

- The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch's titer and quantity of colostral antibodies absorbed by the puppy.

U.S. Veterinary License No. 165A

Schering-Plough Animal Health Corporation, Omaha, NE 68103 USA

1 800 224-5318 (USA)

1 888 306-0069 (Canada)

© Copyright 1999, 2001, 2006, Schering-Plough Animal Health Corp. All rights reserved.

™ Trademark of Schering-Plough Canada Inc.

Nac No.